Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.5%
    Check dated 2025-01-19T22:45:18.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has updated the type of intervention to include a verified status by Daniela Katz M.D. and has revised to version 2.14.0, while the previous version 2.13.3 and its type of intervention have been removed.
    Difference
    0.7%
    Check dated 2025-01-12T17:57:36.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-12-29T07:47:44.000Z thumbnail image
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:40:10.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T15:59:05.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2024-11-30T12:41:15.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.